132 related articles for article (PubMed ID: 33068443)
1. In situ study of cellular immune response in human cutaneous lesions caused by Leishmania (Viannia) panamensis in Panama.
Gonzalez K; Calzada JE; Tomokane TY; Pacheco CMS; Flores GVA; Castro Gomes CM; Pereira Corbett CE; Saldaña A; Laurenti MD
Parasite Immunol; 2021 Mar; 43(3):e12801. PubMed ID: 33068443
[TBL] [Abstract][Full Text] [Related]
2. Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.
Ehrlich AK; Fernández OL; Rodriguez-Pinto D; Castilho TM; Corral Caridad MJ; Goldsmith-Pestana K; Saravia NG; McMahon-Pratt D
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28052994
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the Inflammasome and Th17 Cells in Skin Lesions of Human Cutaneous Leishmaniasis Caused by
Gonzalez K; Calzada JE; Corbett CEP; Saldaña A; Laurenti MD
Mediators Inflamm; 2020; 2020():9278931. PubMed ID: 33192178
[TBL] [Abstract][Full Text] [Related]
4. The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.
Ehrlich A; Castilho TM; Goldsmith-Pestana K; Chae WJ; Bothwell AL; Sparwasser T; McMahon-Pratt D
J Immunol; 2014 Sep; 193(6):2961-70. PubMed ID: 25098291
[TBL] [Abstract][Full Text] [Related]
5. Histopathological characteristics of cutaneous lesions caused by Leishmania Viannia panamensis in Panama.
González K; Diaz R; Ferreira AF; García V; Paz H; Calzada JE; Ruíz M; Laurenti M; Saldaña A
Rev Inst Med Trop Sao Paulo; 2018; 60():e8. PubMed ID: 29451596
[TBL] [Abstract][Full Text] [Related]
6. Molecular Identification of Parasites Causing Cutaneous Leishmaniasis in Panama.
Miranda ADC; González KA; Samudio F; Pineda VJ; Calzada JE; Capitan-Barrios Z; Jiménez A; Castillo J; Mendoza Y; Suárez JA; Ortiz B; Méndez J; Pascale JM; Grögl M; Sosa N; Saldaña A
Am J Trop Med Hyg; 2021 Jan; 104(4):1326-1334. PubMed ID: 33432903
[TBL] [Abstract][Full Text] [Related]
7. Detection of Leishmania RNA Virus 1 in Leishmania (Viannia) panamensis Isolates, Panama.
Gonzalez K; De León SS; Pineda V; Samudio F; Capitan-Barrios Z; Suarez JA; Weeden A; Ortiz B; Rios M; Moreno B; Gundacker ND; Pascale JM; López-Vergès S; Sosa N; Saldaña A; Ábrego LE
Emerg Infect Dis; 2023 Jun; 29(6):1250-1253. PubMed ID: 37209675
[TBL] [Abstract][Full Text] [Related]
8. Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection.
Bosque F; Saravia NG; Valderrama L; Milon G
Scand J Immunol; 2000 May; 51(5):533-41. PubMed ID: 10792848
[TBL] [Abstract][Full Text] [Related]
9. Endemically exposed asymptomatic individuals show no increase in the specific Leishmania (Viannia) panamensis-Th1 immune response in comparison to patients with localized cutaneous leishmaniasis.
Trujillo CM; Robledo SM; Franco JL; Velez ID; Erb KJ; Patiño PJ
Parasite Immunol; 2002; 24(9-10):455-62. PubMed ID: 12654087
[TBL] [Abstract][Full Text] [Related]
10. Performance of immunohistochemistry as a useful tool for the diagnosis of cutaneous leishmaniasis in Panama, Central America.
Gonzalez K; Calzada JE; Díaz R; Paz H; García V; Miranda A; Tomokane T; Puga S; Saldaña A; Laurenti M
Parasitol Int; 2019 Aug; 71():46-52. PubMed ID: 30885795
[TBL] [Abstract][Full Text] [Related]
11. Leishmania (viannia) panamensis-induced cutaneous leishmaniasis in susceptible and resistant mouse strains.
Goto H; Rojas JI; Sporrong L; De Carreira P; Sánchez C; Orn A
Rev Inst Med Trop Sao Paulo; 1995; 37(6):475-81. PubMed ID: 8731258
[TBL] [Abstract][Full Text] [Related]
12. Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs).
Delgado G; Parra-López CA; Vargas LE; Hoya R; Estupiñán M; Guzmán F; Torres A; Alonso C; Velez ID; Spinel C; Patarroyo ME
Parasite Immunol; 2003 Apr; 25(4):199-209. PubMed ID: 12940963
[TBL] [Abstract][Full Text] [Related]
13. Characterization of
Reina AM; Mewa JC; Calzada JE; Saldaña A
Trop Med Infect Dis; 2022 Oct; 7(10):. PubMed ID: 36288023
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical and histopathologic characterization of lesions from patients with localized cutaneous leishmaniasis caused by Leishmania panamensis.
Isaza DM; Restrepo M; Restrepo R; Caceres-Dittmar G; Tapia FJ
Am J Trop Med Hyg; 1996 Oct; 55(4):365-9. PubMed ID: 8916790
[TBL] [Abstract][Full Text] [Related]
15. Expression of Foxp3, TGF-β and IL-10 in American cutaneous leishmaniasis lesions.
Rodrigues FM; Coelho Neto GT; Menezes JG; Gama ME; Gonçalves EG; Silva AR; Laurenti MD; Corbett CE; Silveira FT; Gomes CM
Arch Dermatol Res; 2014 Mar; 306(2):163-71. PubMed ID: 23922083
[TBL] [Abstract][Full Text] [Related]
16. Leishmania Viannia guyanensis, LRV1 virus and extracellular vesicles: a dangerous trio influencing the faith of immune response during muco-cutaneous leishmaniasis.
Olivier M; Zamboni DS
Curr Opin Immunol; 2020 Oct; 66():108-113. PubMed ID: 32877837
[TBL] [Abstract][Full Text] [Related]
17. Metastatic capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in golden hamsters.
Martinez JE; Travi BL; Valencia AZ; Saravia NG
J Parasitol; 1991 Oct; 77(5):762-8. PubMed ID: 1919926
[TBL] [Abstract][Full Text] [Related]
18. Human monocyte infection by Leishmania (Viannia) panamensis. Role of complement receptors and correlation of susceptibility in vitro with clinical phenotype.
Robledo S; Wozencraft A; Valencia AZ; Saravia N
J Immunol; 1994 Feb; 152(3):1265-76. PubMed ID: 8301130
[TBL] [Abstract][Full Text] [Related]
19. The site of cutaneous infection influences the immunological response and clinical outcome of hamsters infected with Leishmania panamensis.
Osorio Y; Melby PC; Pirmez C; Chandrasekar B; Guarín N; Travi BL
Parasite Immunol; 2003 Mar; 25(3):139-48. PubMed ID: 12911522
[TBL] [Abstract][Full Text] [Related]
20. Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.
Castilho TM; Goldsmith-Pestana K; Lozano C; Valderrama L; Saravia NG; McMahon-Pratt D
Eur J Immunol; 2010 Oct; 40(10):2816-29. PubMed ID: 20827674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
